Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025 (Cth)

Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025

I, Avinash Clarke, as delegate of the Minister for Health and Aged Care, make the following determination.

Dated 24 February 2025

Avinash Clarke Assistant Secretary Complementary and Over the Counter Medicines Branch Health Products Regulation Group Department of Health and Aged Care

Contents 1 Name 2 Commencement 3 Authority 4 Interpretation 5 Permissible ingredients 6 Requirements in relation to permissible ingredients being contained in medicine 6A Requirements relating to warning statements on labels 7 Repeals Schedule 1—Specified permissible ingredients and requirements applying to these ingredients when contained in a medicine

Note: This instrument is in 6 volumes: Volume 1: Sections 1–7 (pages 2-4) Schedule 1 (+-)-NARINGENIN–AZULENE Volume 2: Schedule 1 BACILLUS COAGULANS–EVERNIA PRUNASTRI EXTRACT Volume 3: Schedule 1 FABIANA IMBRICATA–JUSTICIA ADHATODA Volume 4: Schedule 1 KADSURA COCCINEA–OYSTER SHELL Volume 5: Schedule 1 P-ALPHA-DIMETHYL STYRENE–TYROSINE Volume 6: Schedule 1 UBIDECARENONE–ZOSTERA MARINA

1 Name This instrument is the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025.

2 Commencement (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this instrument 1 March 2025. 1 March 2025

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument. (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.